CD274 and neoplasm: An example of a theranostic approach to activate the peripheral immune system is a reported pre-clinical study that radiolabeled an anti-PD-L1 antibody, MX001, in order to monitor tumor PD-L1 expression using nuclear imaging during anti-PD-L1 treatment 124.